Publicacións nas que colabora con Francisco Campos Pérez (34)

2024

  1. Differential blood-based biomarkers of subcortical and deep brain small vessel disease

    Therapeutic Advances in Neurological Disorders, Vol. 17

  2. Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

  3. Systemic biomarker associated with poor outcome after futile reperfusion

    European Journal of Clinical Investigation, Vol. 54, Núm. 6

  4. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke

    Journal of Nanobiotechnology, Vol. 22, Núm. 1

2023

  1. Influence of Temperature Chronobiology on Stroke Outcome

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Antihyperthermic Treatment in the Management of Malignant Infarction of the Middle Cerebral Artery

    Journal of Clinical Medicine, Vol. 11, Núm. 10

  2. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  3. Fibrin-Targeted Nanoparticles for Finding, Visualizing and Characterizing Blood Clots in Acute Ischemic Stroke

    Pharmaceutics, Vol. 14, Núm. 10

  4. Involvement of Ceramide Metabolism in Cerebral Ischemia

    Frontiers in Molecular Biosciences, Vol. 9

  5. Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  6. Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers

    Translational Stroke Research, Vol. 13, Núm. 2, pp. 228-237

  7. Sonosensitive capsules for brain thrombolysis increase ischemic damage in a stroke model

    Journal of Nanobiotechnology, Vol. 20, Núm. 1

  8. Surrogate biomarkers of outcome for wake-up ischemic stroke

    BMC Neurology, Vol. 22, Núm. 1

  9. The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction

    Frontiers in Neurology, Vol. 13

  10. sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 171-180

2021

  1. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Random forest-based prediction of stroke outcome

    Scientific Reports, Vol. 11, Núm. 1

  3. STWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage

    Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 528-535

  4. sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies

    Frontiers in Neurology, Vol. 12

2020

  1. Antihyperthermic treatment decreases perihematomal hypodensity

    Neurology, Vol. 94, Núm. 16, pp. E1738-E1748